Gene · 5891
Papers1,940
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,940
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclosporine A Modulates Neuroinflammation-Related Gene Expression Associated with Alzheimer's Disease in SH-SY5Y Neuronal Cell Line: Is Cyclosporine A Beneficial/Detrimental? | Biochem Genet | 2026 | 40750957 | PubTator, text mining | PubMed |
Unraveling the Mechanism of Tangmaikang Granules in Treating Diabetic Kidney Disease Based On UPLC-MS/MS, Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations, and Experimental Validation. | Curr Pharm Biotechnol | 2026 | 40151083 | PubTator, text mining | PubMed |
| Scavenger receptors: key players in the immunological puzzle of lupus. | Front Lupus | 2025 | 41648668 | PubTator, text mining | PubMed |
| Differential Neutrophil and Eosinophil Infiltrations in the Sub-Lining Compartment of Rheumatoid Versus Osteoarthritic Synovium. | Mediterr J Rheumatol | 2025 | 41607604 | PubTator, text mining | PubMed |
| Cerium oxide nanoparticles for enhanced healing of diabetic foot ulcers. | Front Bioeng Biotechnol | 2025 | 41602470 | PubTator, text mining | PubMed |
| From Tea to Topical Agent: Machine Learning and Bioinformatics Reveal KU DING Tea's Anti-UV Ingredients and Mechanisms. | Pharmaceuticals (Basel) | 2025 | 41599630 | PubTator, text mining | PubMed |
| Extracellular vesicles for macrophage reprogramming: an emerging paradigm in immunomodulatory therapeutics. | J Biol Eng | 2025 | 41430279 | PubTator, text mining | PubMed |
| Localized Semaglutide Injection for Hyperinsulinemia-Induced Lymphatic Dysfunction: A Narrative Review Proposing a Promising Metabolic Perspective for Lymphedema Therapy. | Adv Pharm Bull | 2025 | 41403736 | PubTator, text mining | PubMed |
| HMGB1 and Its Signaling Pathway in Osteosarcoma: Current Advances in Targeted Therapy. | Curr Issues Mol Biol | 2025 | 41296391 | PubTator, text mining | PubMed |
| Revealing the anti-inflammatory mechanisms of Bupleurum chinense DC. through network pharmacology and experimental validation. | Nat Prod Res | 2025 | 41248197 | PubTator, text mining | PubMed |
| Bioinformatics analysis for Taohe Chengqi Decoction in treating diabetic kidney disease and cutaneous pruritus based on the theory of "same treatment for different diseases". | Medicine (Baltimore) | 2025 | 41239733 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction, reactive oxygen species, and diabetes mellitus - A triangular relationship: A review. | Biomol Biomed | 2025 | 41128021 | PubTator, text mining | PubMed |
| Extracellular vesicles in metabolic perspective: mechanism and targeted therapy. | J Nanobiotechnology | 2025 | 41084004 | PubTator, text mining | PubMed |
| Identification of Riboflavin Metabolism Pathway in HepG2 Cells Expressing Genotype IV Swine Hepatitis E Virus ORF3 Protein. | Vet Sci | 2025 | 41012837 | PubTator, text mining | PubMed |
| White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis. | Cells | 2025 | 41002375 | PubTator, text mining | PubMed |
| Decoding the functional roles of circular RNAs linked to NF-κB pathway in carcinogenesis. | Discov Oncol | 2025 | 40996665 | PubTator, text mining | PubMed |
| Potential mechanism of Qigebikang tablets in the treatment of allergic rhinitis: Network pharmacology and molecular docking. | Medicine (Baltimore) | 2025 | 40988247 | PubTator, text mining | PubMed |
| Serum Copper and Heart Failure: A Cross-Sectional and In Silico Toxicological Study. | Cardiovasc Toxicol | 2025 | 40988006 | PubTator, text mining | PubMed |
| Reduced FGF9 Leads to Kidney Injury Through Regulating Renal Tubular Epithelial Cell EMT in Diabetes. | J Cell Mol Med | 2025 | 40977522 | PubTator, text mining | PubMed |
| Dioscin initiates dual roles in bladder cancer progression via miR-195-5p/FASN/SLC3A2 axis-mediated cell death mechanisms. | Transl Oncol | 2025 | 40961580 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5891/papers?page=5